Pneumococcal Disease Prophylaxis

Medications for Pneumococcal Infection Prophylaxis

About Pneumococcal Infection Prophylaxis: Involves the taking of medication for the purpose of preventing a pneumococcal disease.

This list of medications come found at the treating this illness, or in some way related to.

Drug name	Rx / OTC	Pregnancy	CSA	Reviews	Rating
Pneumovax 23	Rx	C	N	2 testimonials	0.0
Generic title: pneumococcal 23-polyvalent vaccine systemic Drug course: bacterial vaccines For users: dosage, interactions, side effects For specialists: Prescribing Information

Prevnar 1 3	Rx	C	N	26 testimonials	3.8
Generic title: pneumococcal 13-valent vaccine systemic Drug course: bacterial vaccines For users: dosage, interactions, side effects For specialists: Prescribing Information

pneumococcal 13-valent vaccine	Rx	C	N	2-9 testimonials	3.6
Generic title: pneumococcal 13-valent vaccine systemic Brand title: Prevnar 1 3 Drug course: bacterial vaccines For users: dosage, interactions, For specialists: A-Z Drug Facts

pneumococcal 23-polyvalent vaccine	Rx	C	N	9 testimonials	2.5
Generic title: pneumococcal 23-polyvalent vaccine systemic Brand title: Pneumovax 23 Drug course: bacterial vaccines For users: dosage, interactions, For professionals: A-Z Drug Facts

Rx	Prescription Only
OTC	Over the Counter
Rx/OTC	Prescription or Over The Counter
Away Prizes	This medication may not be approved by the FDA for treating the illness.

Pregnancy Category
A	Adequate and well-controlled studies have failed to demonstrate a risk to the embryo in the first trimester of pregnancy (also there`s no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in elderly women.
C	Animal research studies have demonstrated an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks.
D	there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in elderly women clearly outweigh potential rewards.
N	FDA have not classified the drug.

Controlled Substances Act (CSA) Program
N	Is not subject to the Controlled Substances Act.
Inch	Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision.
2	Has a high potential for abuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may cause severe psychological or physical dependency.
3	Has a possibility for abuse less than people in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to physical dependence or high psychological dependence.
4	Has a minimal potential for abuse in accordance with people in program 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to people in program 3.
5	Has a minimal potential for abuse in accordance with people in program 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence.

Alcohol
X	Interacts with Medication.

Always ask with your physician to ensure the information displayed on these pages pertains to some circumstances.